Carerx Corporation · TSX:CRRX
Carerx — Investor Presentation (November 2023)
16 slides from Carerx's investor presentation, Nov 23, 2023
Slide 1: Canada's Largest Seniors Care Pharmacy Provider
Canada’s Largest Seniors Care Pharmacy Provider TSX: CRRX Investor Presentation November 2023
Slide 2: Forward Looking Statements
Forward Looking Statements Certain of the statements contained in this presentation are "forward looking information within the meaning of applicable Canadian securities legislation. Forward looking information includes, but is not limited to, business strategy, plans and other expectations, beliefs
Slide 3: Canada's largest provider of essential pharmacy services to seniors
Canada’s largest provider of essential pharmacy services to seniors housing communities and other congregate care settings 3 3
Slide 4: Comprehensive Institutional Pharmacy Services Offering
Comprehensive Institutional Pharmacy Services Offering Resident Dispensing Services Equipment & CareRx Prescriber Technology Pharmacy - Robotic packaging of - Medication and multi-dose compliance treatment carts with strips tablets - Optical verification - Digital prescribing Medication technology t
Slide 5: Growing National Scale
Growing National Scale ~94,000 26 beds serviced fulfillment centres >1,500 5+ seniors housing year average contract term communities with our largest customers Strongest network in the sector serving the largest 5 seniors home operators in Canada
Slide 6: Successful Execution of Acquisition Strategy
Successful Execution of Acquisition Strategy Proven ability to acquire at accretive multiples, rapidly integrate and realize synergies May 2020 April 2021 June 2021 August 2021 March 2022 Remedy’sRx SmartMeds Rexall Medical Hogan Specialty Pharmacy Pharmacies Pharmacy Partners LTC Pharmacy +18,500 b
Slide 7: Successful Execution of Our Growth Strategy
Successful Execution of Our Growth Strategy Average Beds Serviced Revenue Adj. EBITDA (000s) (from continuing ops) (from continuing ops) ($ millions) ($ millions) 381.7 32.3 96 74 262.6 22.9 45 162.2 12.8 31 124.6 9.4 FY '19 FY '20 FY '21 FY '22 FY '19 FY '20 FY '21 FY '22 FY '19 FY '20 FY '21 FY '2
Slide 8: BD Rowa Update
BD Rowa Update • Commenced packaging in Q1 2023 • Innovative technology enabling higher volumes without additional labour costs, improved accuracy and reduced downtime • Over 11,000 beds serviced at end of Q3 2023 • Expect 13,000 beds to be online in Q4 2023 Optimized, higher volume and speed of dis
Slide 9: Strategic Priorities
Strategic Priorities Optimize business operations Strengthen balance sheet and improve cash generation Continue to grow revenue Expand industry advocacy efforts 9
Slide 10: Optimize Business Operations
Optimize Business Operations • Procurement initiatives and best practices to augment purchasing power • Standardized operating model and policies and procedures to enhance operational efficiencies • Introducing Lean methodology to generate data-driven decisions that increase productivity, promote co
Slide 11: Multiple Paths For Growth
Multiple Paths For Growth ~94,0001 beds Grow with existing customers 19% • LTC occupancy increasing post-Covid • Home operators expanding through increased capacity, new Current Market >500,000 available beds1 construction, new bed license allocations and acquisitions 81% • Increased penetration and
Slide 12: The CareRx Advantage
The CareRx Advantage 1 2 3 Strong leadership position as Multiple growth opportunities Stable, highly predictable Canada’s largest operator and recurring revenues from large, growing partners 4 5 6 Deep and experienced Proprietary technologies and High barriers to entry for new leadership team progr
Slide 13: Appendix
Canada’s Largest Seniors Care Pharmacy Provider TSX: CRRX Appendix
Slide 14: Balance Sheet
Balance Sheet At Sep 30/23 Total Debt1 at Sep 30/23 $13.2 M Cash $36.4 M Net Debt1 $57.0 M $20.0 M $58.0 M Net Debt to Adjusted EBITDA2 1.9x $2.2 M March 2019 Convertible Debentures Subordinated Debt Hogan Vendor Take-Back Note 14 1. Debt = borrowings (principal) not including November 2019 Converti
Slide 15: Capital Structure
Capital Structure Shares Outstanding (000’s) Ownership 70,000 2,442 64,356 Fully Diluted Ownership 2,083 59,831 Yorkville Asset Management 16,521,306 25.7% 50,000 Management & Insiders 7,572,387 11.8% Other 40,261,870 62.6% 30,000 Total 64,355,563 100% 10,000 Current I/O Convertible Other Outstandin
Slide 16: Investor Presentation
Canada’s Largest Seniors Care Pharmacy Provider TSX: CRRX Investor Presentation November 2023